These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors. Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616 [TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208 [TBL] [Abstract][Full Text] [Related]
5. Classification of neuroendocrine tumors. Klöppel G Verh Dtsch Ges Pathol; 1997; 81():111-7. PubMed ID: 9474861 [TBL] [Abstract][Full Text] [Related]
6. Pathology - grading and staging of GEP-NETs. Capelli P; Fassan M; Scarpa A Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):705-17. PubMed ID: 23582914 [TBL] [Abstract][Full Text] [Related]
7. Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible? Grillo F; Albertelli M; Annunziata F; Boschetti M; Caff A; Pigozzi S; Ferone D; Mastracci L Endocrine; 2016 Jul; 53(1):58-62. PubMed ID: 26362059 [TBL] [Abstract][Full Text] [Related]
8. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors. Karakuş E; Helvacı A; Ekinci O; Dursun A Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137 [TBL] [Abstract][Full Text] [Related]
9. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center. Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181 [TBL] [Abstract][Full Text] [Related]
10. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Klöppel G; Perren A; Heitz PU Ann N Y Acad Sci; 2004 Apr; 1014():13-27. PubMed ID: 15153416 [TBL] [Abstract][Full Text] [Related]
11. Recent updates on grading and classification of neuroendocrine tumors. Kim JY; Hong SM; Ro JY Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335 [TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria. Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925 [TBL] [Abstract][Full Text] [Related]
13. Recent classifications systems for gastroenteropancreatic neuroendocrine tumors A single-center experience. Yagmur Y; Söğutcü N; Gümüş S Ann Ital Chir; 2020; 91():598-604. PubMed ID: 32989209 [TBL] [Abstract][Full Text] [Related]
14. Digestive neuroendocrine tumors: reclassifying of 26 cases according to 2010 who classification. Chaabane A; M'sakni I; Laabidi B; Bougrine F; Bouziani A Tunis Med; 2016 Oct; 94(8-9):580-586. PubMed ID: 28685792 [TBL] [Abstract][Full Text] [Related]
15. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms]. Couvelard A; Scoazec JY Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641 [TBL] [Abstract][Full Text] [Related]
16. Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature. Neychev V; Kebebew E Int J Surg Oncol; 2017; 2017():6424812. PubMed ID: 28593056 [TBL] [Abstract][Full Text] [Related]
17. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research]. Luley K; Gebauer J; Gebauer N; Tharun L; Buchmann I; Barkhausen J; von Bubnoff N; Lindner K; Keck T; Lehnert H; Schmid SM Internist (Berl); 2020 Aug; 61(8):875-890. PubMed ID: 32676723 [TBL] [Abstract][Full Text] [Related]
18. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636 [TBL] [Abstract][Full Text] [Related]